Research & Development

How Will NIH Grant Help Fight Multidrug-Resistant Bacterial Infections?
Research & Development How Will NIH Grant Help Fight Multidrug-Resistant Bacterial Infections?

Imagine facing a post-antibiotic era where previously manageable infections become deadly due to rampant multidrug-resistant bacteria. This emerging threat to global health has pushed scientists to innovate to avert a crisis. The National Institutes of Health (NIH) has awarded $3.96 million to

Can Targeting USP39 Improve Treatments for Retinitis Pigmentosa and Cancer?
Research & Development Can Targeting USP39 Improve Treatments for Retinitis Pigmentosa and Cancer?

The discovery of a critical mechanism involving the protein USP39 has opened new avenues for understanding and potentially treating diseases like retinitis pigmentosa and certain cancers. Researchers have revealed that USP39 plays a crucial role in maintaining the stability of spliceosome subunits

How Is Benitec Biopharma Advancing BB-301 Gene Therapy for OPMD?
Research & Development How Is Benitec Biopharma Advancing BB-301 Gene Therapy for OPMD?

Benitec Biopharma Inc., headquartered in Hayward, California, has recently released its financial results for the first quarter of fiscal 2025. Alongside this, the company has provided an extensive operational update, highlighting significant clinical progress, financial health, and a detailed

Microbial Load's Impact on Gut Health and Disease Revealed in New Study
Research & Development Microbial Load's Impact on Gut Health and Disease Revealed in New Study

Some studies presents an in-depth analysis of how the density of microorganisms, or microbial load, in the human gut can impact overall health and contribute to various diseases. This relatively new dimension of gut microbiome research, as illustrated by the study conducted by the Bork group at

ARTBIO and 3B Pharma Collaborate on Novel Alpha Radioligand Therapy
Research & Development ARTBIO and 3B Pharma Collaborate on Novel Alpha Radioligand Therapy

In a significant move for the oncology field, ARTBIO, Inc. has entered into a groundbreaking partnership with 3B Pharmaceuticals GmbH that aims to advance a novel alpha radioligand therapy for treating solid tumors. ARTBIO, known for its innovative AlphaDirect™ platform, focuses on 212Pb-based a

Can FDA Fast Track and Accelerated Approval Expedite Drug Access?
Research & Development Can FDA Fast Track and Accelerated Approval Expedite Drug Access?

The development and review timelines for new drugs are critical in addressing the immediate medical needs of patients with serious conditions. In this context, the United States Food and Drug Administration (FDA)’s Fast Track and Accelerated Approval pathways play a pivotal role. These regulatory f

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later